IL6 and prostate carcinoma: These observations are in agreement, with several reports demonstrating that IL6, which belongs to the LIF family, favors the transition toward cancer stem cells in breast and prostate cancers [23], and increases mesenchymal transition of melanoma cells and melanoma tumor development [24].